remove_red_eye 462 Views
#Cardiology #Hematology #Oncology #Public Health
Patients with non-metastatic HER2-positive breast cancer who take carvedilol at the same time as trastuzumab have less heart damage, according to a study presented Dec. 5, 2018 at EuroEcho-Imaging 2018. These findings indicate that carvedilol may be an effective way to prevent the heart damage caused by trastuzumab treatment.
Continue reading your article with a Emedinexus account..